272 related articles for article (PubMed ID: 7744586)
1. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
Saute M
Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
[TBL] [Abstract][Full Text] [Related]
2. Video-assisted management of malignant pleural effusion in breast carcinoma.
Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
[TBL] [Abstract][Full Text] [Related]
3. [Current treatment strategy in malignant pleural effusion].
Türler A; Walter M; Schmitz-Rixen T
Wien Klin Wochenschr; 1996; 108(9):255-61. PubMed ID: 8686317
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of malignant pleural effusion by pleurodesis with talc].
Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
[TBL] [Abstract][Full Text] [Related]
5. [Talc--a standard drug in the treatment of malignant pleural effusion].
Bednár M; Bezdícek P
Cas Lek Cesk; 1999 Jan; 138(3):82-4. PubMed ID: 10376391
[TBL] [Abstract][Full Text] [Related]
6. Pleural malignancies.
Vargas FS; Teixeira LR
Curr Opin Pulm Med; 1996 Jul; 2(4):335-40. PubMed ID: 9363162
[TBL] [Abstract][Full Text] [Related]
7. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
8. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
Hoksch B; Seidel N; Beshay M; Schmid RA
Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
[TBL] [Abstract][Full Text] [Related]
9. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
10. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
Neragi-Miandoab S
Lung Cancer; 2006 Oct; 54(1):1-9. PubMed ID: 16893591
[TBL] [Abstract][Full Text] [Related]
12. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting.
Petrou M; Kaplan D; Goldstraw P
Cancer; 1995 Feb; 75(3):801-5. PubMed ID: 7530167
[TBL] [Abstract][Full Text] [Related]
13. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
14. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
15. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
16. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Walter M; Türler A; Schmitz-Rixen T
Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
[TBL] [Abstract][Full Text] [Related]
17. [Effective treatment of malignant pleural effusion: Thoracoscopic talcum pleurodesis and pleuro-peritoneal shunt].
Böhle AS; Kurdow R; Dohrmann P; Henne-Bruns D
Dtsch Med Wochenschr; 1999 Mar; 124(12):341-5. PubMed ID: 10214366
[TBL] [Abstract][Full Text] [Related]
18. Update on talc, bleomycin, and the tetracyclines in the treatment of malignant pleural effusions.
Schafers SJ; Dresler CM
Pharmacotherapy; 1995; 15(2):228-35. PubMed ID: 7542766
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
20. Management of malignant pleural effusions by talc pleurodesis.
Waqainabete I
Pac Health Dialog; 2006 Sep; 13(2):103-5. PubMed ID: 18181397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
